Healthcare DIVE March 24, 2025

Sponsored content By RxSense

The growing demand for PBM insourcing

For decades, the three largest PBMs have dominated the market, controlling 70% of pharmacy benefits nationwide. Yet, dissatisfaction with their services has reached a decade-long high. A 2023 survey by Pharmaceutical Strategies Group revealed that organizations are increasingly frustrated with a lack of flexibility, limited transparency and misaligned incentives.

Organizations—including health systems, health plans, large employers, and grocers—seek a tailored pharmacy benefit solution that offers greater control, flexibility and transparency. Rather than relying on legacy PBMs with misaligned incentives and varying strategies, they are turning to insourcing their pharmacy benefits as a strategic alternative.

“The primary reason for the shift away from the big three PBMs to new alternatives is...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Pharma, Pharma / Biotech
Makary’s FDA Has Options In Industry Fight Over Weight Loss Drugs
Faster Cancer Drug Approvals Tied to Clinical Benefits
The Future of PBMs in 2025: AI, Regulations, and Transparency Initiatives
Q&A: Pharmacy Closures, PBM Reform, and How Pharmacists Can Effectively Advocate
Ethical Considerations for AI Use in Medication Access

Share This Article